Patient-Reported Outcomes in Vitiligo: QoL Scales, Minimal Important Change, and Clinic Integration
Key Takeaways Why measure QoL? VASI captures extent, but not impact (stigma, avoidance, mood). PROMs close that gap. Core tools: […]
DLQI
Patient-Reported Outcomes in Vitiligo: DLQI, Vitiligo-Specific Scales, and What Counts as Clinically Meaningful
Key Takeaways Why PROMs? Pigment changes affect visibility, stigma, and function. PROMs help prioritize sites (e.g., face/hands) and set goals
Psychosocial Impact of Vitiligo: Quality of Life, Stigma, and Support Strategies
Key Takeaways Vitiligo imposes a clinically meaningful quality-of-life (QoL) burden; facial and visible-area involvement, rapid progression, and darker phototypes are
Vitiligo Epidemiology & Disease Burden: Global Prevalence, Children vs Adults, Quality of Life
Key Takeaways Global point prevalence typically falls within ~0.5–2%, with heterogeneity by region and methodology. Childhood onset is common (≈30–50%